Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 96
Plenary
Progress in Gene Therapy for HIV Cure
Paula M. Cannon
University of Southern California, Los Angeles, CA, United States
podium video slides video slides + audio mp3
from CROI 2016 on February 24, 2016 8:30 AM-9:00 AM
Plenary
HIV in Transgender Populations: Charted and Uncharted Waters
Tonia C. Poteat
Johns Hopkins University, Baltimore, MD, United States
podium video slides video slides + audio mp3
from CROI 2016 on February 24, 2016 9:00 AM-9:30 AM
Oral Abstract: Drugs: From Discovery to Challenges in Clinical Use
Pharmacologic Measures of Adherence and Relationship to Drug Response
Peter L Anderson
University of Colorado, Denver, CO, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Drugs: From Discovery to Challenges in Clinical Use
HIV-1 Combinectin BMS-986197: A Long-Acting Inhibitor With Multiple Modes of Action
Mark Krystal
Bristol-Myers Squibb, Wallingford, CT, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Drugs: From Discovery to Challenges in Clinical Use
Long-Acting Oral and Parenteral Dosing of MK-8591 for HIV Treatment or Prophylaxis
Jay Grobler
Merck & Co, West Point, PA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Drugs: From Discovery to Challenges in Clinical Use
Lower Ribavirin Exposures in HIV+ Patients That Relapsed to Acute HCV Treatment
Christine E. MacBrayne
University of Colorado, Denver, CO, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Drugs: From Discovery to Challenges in Clinical Use
Drug Interaction Studies Between Sofosbuvir/Velpatasvir and Boosted HIV ARV Regimens
Erik Mogalian
Gilead Sciences, Foster City, CA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Drugs: From Discovery to Challenges in Clinical Use
EFV Reduced PK of Piperaquine for Malaria Prevention in HIV+ Ugandan Pregnant Women
Richard Kajubi
Makerere University, Kampala, Uganda
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Drugs: From Discovery to Challenges in Clinical Use
Concentrations of TFV and TFVdp in Female Mucosal Tissues After a Single Dose of TAF
Katy L. Garrett
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Expanding the Toolbox for Prevention
HPTN 069/ACTG 5305: Phase II Study of Maraviroc-Based Regimens for HIV PrEP in MSM
Roy Gulick
Weill Cornell Medical College, New York, NY, United States
podium video slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Expanding the Toolbox for Prevention
PrEP Impact on T-Cell Activation and Explant Infection: HPTN 069/ACTG 5305 Substudy
Ian McGowan
University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
podium video slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Expanding the Toolbox for Prevention
Cabotegravir Long-Acting Injection Protects Macaques Against Intravenous Challenge
Chasity D. Andrews
Aaron Diamond AIDS Research Center, New York, NY, United States
podium video slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Expanding the Toolbox for Prevention
ÉCLAIR: Phase 2A Safety and PK Study of Cabotegravir LA in HIV-Uninfected Men
Martin Markowitz
Aaron Diamond AIDS Research Center, New York, NY, United States
podium video slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Expanding the Toolbox for Prevention
Chemoprophylaxis With Oral FTC/TAF Protects Macaques From Rectal SHIV Infection
Gerardo Garcia-Lerma
Centers for Disease Control and Prevention, Atlanta, GA, United States
podium video slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Expanding the Toolbox for Prevention
MTN-017: Rectal Phase 2 Extended Safety and Acceptability Study of 1% Tenofovir Gel
Ross Cranston
University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
podium video slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Expanding the Toolbox for Prevention
A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention in Women
Jared M. Baeten
University of Washington, Seattle, WA, United States
podium video slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Expanding the Toolbox for Prevention
Safety and Efficacy of Dapivirine Vaginal Ring for HIV-1 Prevention in African Women
Annalene Nel
International Partnership for Microbicides, Paarl, South Africa
podium video slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Getting to 90-90-90
Oral Abstract Moderator
Marco Vitoria
World Health Organization, Geneva, Switzerland
slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Getting to 90-90-90
Botswana Is Close to Meeting UNAIDS 2020 Goals of 90-90-90 Coverage
Tendani Gaolathe
Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Getting to 90-90-90
Streamlining Antiretroviral Therapy Uptake: A Stepped-Wedge Cluster Randomized Trial
Gideon Amanyire
Makerere University College of Health Sciences, Kampala, Uganda
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Getting to 90-90-90
A Randomized Trial to Accelerate HIV Care and ART Initiation Following HIV Diagnosis
Christopher Hoffmann
Johns Hopkins University School of Medicine, Baltimore, MD, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Getting to 90-90-90
Towards the Second UNAIDS Target: Population-Level ART Coverage in HPTN 071 (PopART)
Sarah J. Fidler
Imperial College London, London, United Kingdom
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Getting to 90-90-90
Optimising South Africa's HIV Response: Results of the HIV and TB Investment Case
Calvin Chiu
University of the Witwatersrand, Johannesburg, South Africa
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Getting to 90-90-90
Virologic Efficacy of ART Begun at High CD4+ Counts via Streamlined Care in East Africa
Dalsone Kwarisiima
Makerere University-University of California San Francisco Research Collaboration, Kampala, Uganda
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Getting to 90-90-90
HIV Mortality by Care Cascade Stage and Implications for Universal ART Eligibility
Jeffrey W. Eaton
Imperial College London, London, United Kingdom
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Getting to 90-90-90
Trends in ART Discontinuation by Age in Malawi, 2004-2014
Catrina Andrea Mugglin
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Pushing Frontiers of Adaptive Immunity
An Infant bNAb With Low Somatic Hypermutation Contributes to Polyclonal Breadth
Cassandra Simonich
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Pushing Frontiers of Adaptive Immunity
Virus, Host, and Disease Factors Govern HIV-1 Broadly Neutralizing Antibody Induction
Alexandra Trkola
University of Zurich, Zurich, Switzerland
slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Pushing Frontiers of Adaptive Immunity
Clinical Safety and Pharmacokinetics of IV and SC VRC01, a Broadly Neutralizing mAb
Kenneth H. Mayer
The Fenway Institute, Fenway Health, Boston, MA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Pushing Frontiers of Adaptive Immunity
Neutrophil Functions Induced by Gp-120 Specific IgA and IgG; Clues for Immunotherapy
Magdalena Sips
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Pushing Frontiers of Adaptive Immunity
Potency and Kinetics of Autologous HIV-1 Neutralizing Antibody Responses During ATI
Brenda Salantes
University of Pennsylvania, Philadelphia, PA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Pushing Frontiers of Adaptive Immunity
PD-1 Blockade as an Adjunct Therapy to ART and Potential to Destabilize SIV Reservoir
Geetha Mylvaganam
Emory University, Atlanta, GA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Pushing Frontiers of Adaptive Immunity
Follicular CTL Accumulate in SIV-Infected Lymph Nodes Due to Immune Activation
Costantinos Petrovas
National Institutes of Health, Bethesda, MD, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Pushing Frontiers of Adaptive Immunity
Repeated TLR7 Agonist Treatment of SIV+ Monkeys on ART Can Lead to Viral Remission
James B. Whitney
Beth Israel Deaconess Medical Center, Boston, MA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Reservoirs, Relapse, and Remission
Investigating the Mechanisms that Control HIV Transcription and Latency In Vivo
Steven A. Yukl
San Francisco VA Medical Center, San Francisco, CA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Reservoirs, Relapse, and Remission
Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation
Mohamed Abdel-Mohsen
Blood Systems Research Institute, San Francisco, CA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Reservoirs, Relapse, and Remission
PD-1+ and Tfh Cells Represent the Major Source of HIV-1 Replication-Competent Virus
Riddhima Banga
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Reservoirs, Relapse, and Remission
Rapid Accumulation of Defective Proviruses Complicates HIV-1 Reservoir Measurements
Katherine M. Bruner
Johns Hopkins University School of Medicine, Baltimore, MD, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Reservoirs, Relapse, and Remission
Clones of SIV-Infected Cells Are Present in Spleen and Lymph Nodes in Rhesus Macaques
Stephen H. Hughes
National Cancer Institute, Frederick, MD, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Reservoirs, Relapse, and Remission
ART Reduces Cellular HIV RNA but Not the Fraction of Proviruses Transcribing RNA
Mary F. Kearney
National Cancer Institute, Frederick, MD, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Reservoirs, Relapse, and Remission
Restricted HIV-1 Diversity and Clonal Expansion Following Cytoreductive Chemotherapy
Emily Hanhauser
University of California San Francisco, San Francisco, CA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Oral Abstract: Reservoirs, Relapse, and Remission
Virological Remission After ART Interruption in African HIV-1 Seroconverters
Morgane Gossez
University of Oxford, Oxford, United Kingdom
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 10:00 AM-12:00 PM
Wednesday Press Conference
Discussion of Oral Abstract Session 10 – Getting to 90-90-90 and Symposium Session 5 – Reaching 90-90-90 and Beyond: Challenges and Innovations
Chair
Diane Havlir
University of California, San Francisco, CA, United States
OA10: Botswana Is Close to Meeting UNAIDS 2020 Goals of 90-90-90 Coverage
Tendani Gaolathe
Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana
OA10: Streamlining Antiretroviral Therapy Uptake: A Stepped-Wedge Cluster Randomized Trial
Gideon Amanyire
Makerere University College of Health Sciences, Kampala, Uganda
OA10: HIV Mortality by Care Cascade Stage and Implications for Universal ART Eligibility
Jeffrey Eaton
Imperial College London, London, United Kingdom
SS5: Missing But in Action: Where Are the Men?
Helen Ayles
London School of Hygiene & Tropical Medicine, London, United Kingdom
SS5: Innovations in Antiretroviral Therapy Delivery
Anna Grimsrud
International AIDS Society, Cape Town, South Africa
video audio mp3
from CROI 2016 on February 24, 2016 12:30 PM-1:30 PM
Wednesday Press Conference
Discussion of Oral Abstract Session 9 – Expanding the Toolbox for Prevention and Themed Discussion Session 12 – It's Complicated: Renal Function and STIs in PrEP Users and Poster Abstract Session 3 – Predictors of PrEP Coverage and Uptake
Chair
Sharon L. Hillier
University of Pittsburgh School of Medicine, Magee-Womens Hospital, PA, United States
OA9: ÉCLAIR: Phase 2A Safety and PK Study of Cabotegravir LA in HIV Uninfected Men
Martin Markowitz
Aaron Diamond AIDS Research Center, New York, NY, United States
TD12: Higher Cumulative TFV/FTC Levels in PrEP Associated With Decline in Renal Function
Monica Gandhi
University of California San Francisco, San Francisco, CA, United States
TD12: Changes in Renal Function Associated With TDF/FTC PrEP Use in the US Demo Project
Albert Y. Liu
San Francisco Dept of Public Health, San Francisco, CA, United States
TD12: STI Data From Community-Based PrEP Implementation Suggest Changes to CDC Guidelines
Sarit A. Golub
Hunter College, City University of New York, NY, United States
PAS3: HPTN 073: PrEP Uptake and Use by Black Men Who Have Sex With Men in 3 US Cities
Darrell P. Wheeler
State University of New York at Albany, Albany, NY, United States
video audio mp3
from CROI 2016 on February 24, 2016 12:30 PM-1:30 PM
Themed Discussion: Cryptococcal Disease: Detection and Complications
Maximizing Detection and Improving Outcomes of Cryptococcosis in Rural Tanzania
Emilio Letang
Swiss Tropical Institute of Public Health, Basel, Switzerland
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 1:45 PM-2:45 PM
Themed Discussion: Cryptococcal Disease: Detection and Complications
Evaluation of Provider-Initiated Cryptococcal Antigen Screening, South Africa
Nicky Longley
St George's University of London, London, United Kingdom
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 1:45 PM-2:45 PM
Themed Discussion: Cryptococcal Disease: Detection and Complications
Immunologic Discrimination of Cryptococcal IRIS From Culture-Positive Relapse
David R. Boulware
University of Minnesota, Minneapolis, MN, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 1:45 PM-2:45 PM
Themed Discussion: Cryptococcal Disease: Detection and Complications
Neurocognitive Function in HIV-Infected Persons With Cryptococcal Antigenemia
Martha P. Montgomery
University of Minnesota, Minneapolis, MN, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 1:45 PM-2:45 PM
Themed Discussion: Cryptococcal Disease: Detection and Complications
Questions and Answers
slides + audio mp3
from CROI 2016 on February 24, 2016 1:45 PM-2:45 PM
Themed Discussion: HIV and Microbiomes
Themed Discussion Leader
Nichole Klatt
University of Washington, Seattle, WA, United States
slides video slides + audio mp3
from CROI 2016 on February 24, 2016 1:45 PM-2:45 PM
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 96